Dimed S.A. Distribuidora de Medicamentos (BVMF: PNVL3)

PNVL3 Statistics

Total Valuation

Dimed S.A. Distribuidora de Medicamentos has a market cap or net worth of BRL 1.49 billion. The enterprise value is 2.34 billion.

Market Cap	1.49B
Enterprise Value	2.34B

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	Jun 27, 2024

Share Statistics

Dimed S.A. Distribuidora de Medicamentos has 149.36 million shares outstanding. The number of shares has decreased by -0.79% in one year.

Shares Outstanding	149.36M
Shares Change (YoY)	-0.79%
Shares Change (QoQ)	+14.88%
Owned by Insiders (%)	46.35%
Owned by Institutions (%)	15.29%
Float	80.13M

Valuation Ratios

The trailing PE ratio is 16.39 and the forward PE ratio is 9.07.

PE Ratio	16.39
Forward PE	9.07
PS Ratio	0.32
PB Ratio	1.27
P/FCF Ratio	6.79
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.69, with an EV/FCF ratio of 10.64.

EV / Earnings	25.62
EV / Sales	0.50
EV / EBITDA	8.69
EV / EBIT	14.63
EV / FCF	10.64

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 95.33.

Current Ratio	1.58
Quick Ratio	0.69
Debt / Equity	95.33
Debt / EBITDA	4.15
Debt / FCF	5.08
Interest Coverage	1.51

Financial Efficiency

Return on equity (ROE) is 7.95% and return on invested capital (ROIC) is 4.53%.

Return on Equity (ROE)	7.95%
Return on Assets (ROA)	3.37%
Return on Capital (ROIC)	4.53%
Revenue Per Employee	474,938
Profits Per Employee	9,207
Employee Count	10,284
Asset Turnover	1.59
Inventory Turnover	3.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.74% in the last 52 weeks. The beta is 0.41, so Dimed S.A. Distribuidora de Medicamentos's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-14.74%
50-Day Moving Average	10.29
200-Day Moving Average	11.13
Relative Strength Index (RSI)	40.70
Average Volume (20 Days)	391,935

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dimed S.A. Distribuidora de Medicamentos had revenue of BRL 4.71 billion and earned 91.34 million in profits. Earnings per share was 0.61.

Revenue	4.71B
Gross Profit	1.48B
Operating Income	159.93M
Pretax Income	85.61M
Net Income	91.34M
EBITDA	139.29M
EBIT	159.93M
Earnings Per Share (EPS)	0.61

Balance Sheet

The company has 270.59 million in cash and 1.12 billion in debt, giving a net cash position of -846.29 million or -5.67 per share.

Cash & Cash Equivalents	270.59M
Total Debt	1.12B
Net Cash	-846.29M
Net Cash Per Share	-5.67
Equity (Book Value)	1.17B
Book Value Per Share	7.84
Working Capital	694.21M

Cash Flow

In the last 12 months, operating cash flow was 321.29 million and capital expenditures -101.30 million, giving a free cash flow of 219.99 million.

Operating Cash Flow	321.29M
Capital Expenditures	-101.30M
Free Cash Flow	219.99M
FCF Per Share	1.47

Margins

Gross margin is 31.45%, with operating and profit margins of 3.39% and 1.94%.

Gross Margin	31.45%
Operating Margin	3.39%
Pretax Margin	1.82%
Profit Margin	1.94%
EBITDA Margin	2.96%
EBIT Margin	3.39%
FCF Margin	4.67%

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 2.50%.

Dividend Per Share	0.25
Dividend Yield	2.50%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	36.03%
Buyback Yield	0.79%
Shareholder Yield	3.30%
Earnings Yield	6.10%
FCF Yield	14.73%

Stock Splits

The last stock split was on March 23, 2020. It was a forward split with a ratio of 30.

Last Split Date	Mar 23, 2020
Split Type	Forward
Split Ratio	30